RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100

RelB mediates the constitutive nuclear pool of NF-κB transcriptional activity in myeloid and lymphoid cells, which is believed to be secondary to its weak interaction with the classical NF-κB inhibitor proteins, the IκBs. In other cell types, RelB is located in the cytosol, thus suggesting that R...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 277; no. 2; pp. 1405 - 1418
Main Authors Solan, Nancie J, Miyoshi, Hiroko, Carmona, Eva M, Bren, Gary D, Paya, Carlos V
Format Journal Article
LanguageEnglish
Published United States American Society for Biochemistry and Molecular Biology 11.01.2002
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:RelB mediates the constitutive nuclear pool of NF-κB transcriptional activity in myeloid and lymphoid cells, which is believed to be secondary to its weak interaction with the classical NF-κB inhibitor proteins, the IκBs. In other cell types, RelB is located in the cytosol, thus suggesting that RelB is also regulated by an inhibitory protein(s). In this study, it is demonstrated that RelB is associated in the cytosol with p100 but not with IκBα, IκBβ, IκBε, nor p105. Its cytosolic control is not affected by stimuli that lead to RelA nuclear translocation, and RelB nuclear localization is prevented by p100, but not by p105 or IκBα. Structure function analysis p100-RelB interactions indicates that p100 amino acids 623–900 are required for effective interaction and repression of nuclear translocation and RelB driven NF-κB-dependent transcription. Moreover, this carboxyl-portion of p100 contains a nuclear export signal(s), which is required for effective retrieval of RelB from the nucleus. Finally, overexpression of NF-κB-inducing kinase, a kinase that has recently been shown to induce p100 processing, possibly through IKKα activation, causes nuclear translocation of RelB protein. Thus, these studies indicate that p100 is a bone fide inhibitor of RelB and that this transcription factor may be regulated by NF-κB-inducing kinase and/or IKKα.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M109619200